A Phase 3 Study of Fluvoxamine (SME3110) in Pediatric/Adolescent Patients With Obsessive Compulsive Disorder

Clinical trial NCT01933919 · COMPLETED

Trial details

NCT number: NCT01933919
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obsessive Compulsive Disorder

Start date: 2013-08-14
Primary completion: 2015-06-18
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.